- Presentations
- 2
- Brands
- 1
- Manufacturers
- 1
- Available from stock
- 0
Tisagenlecleucel is a autologous. MedsAcross lists 2 presentations of it from 1 manufacturers, with brand names, strengths, packs and regulatory status for each. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Autologous, CD19-directed Chimeric Antigen Receptor, Cultured, Genetically-modified, Genetically-modified Autologous T Cells, T Lymphocytes, CD19 Receptor Interactions, Increased T Lymphocyte Activation
- ATC classification
- L01XL04 Tisagenlecleucel · Cancer medicines (antineoplastics), subgroup L01X, subgroup L01XL
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- Yes
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Intravenous
- Dosage forms
- Injectable suspension
- Biologic
- Yes
- Identifiers
- UNII Q6C9WHR03ORxCUI 1986438Q30314624
All presentations
2 presentations of Tisagenlecleucel, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Kymriah 2000000 injectable suspensionIntravenous | Novartis Pharmaceuticals | US FDA | Available on request |
| Kymriah 60000000 injectable suspensionIntravenous | Novartis Pharmaceuticals | US FDA | Available on request |
Brands by market
1 brand names across 1 markets.
United States
Manufacturers
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Conditions
Conditions linked to Tisagenlecleucel in public data. This is not a list of approved uses, see the clinical information.
Questions and answers
Is Tisagenlecleucel available for export from India?
Yes, on request. MedsAcross lists 2 presentations of Tisagenlecleucel and sources them for licensed hospitals, importers and physicians against valid import documents.
What brand names does Tisagenlecleucel have?
The catalogue lists 1 brand names for Tisagenlecleucel, including Kymriah.
Is Tisagenlecleucel authorised in the European Union?
Yes. Tisagenlecleucel has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Tisagenlecleucel need cold chain shipping?
No listed presentation of Tisagenlecleucel is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Tisagenlecleucel in?
Tisagenlecleucel is classified under ATC code L01XL04 (Tisagenlecleucel).
References
- Kymriah: European public assessment report (EPAR). European Medicines Agency. Retrieved 1 September 2026
Request Tisagenlecleucel for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.